InsiderTrades

Form 4 for ACMR ACM Research, Inc.

Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-19 · accession 0001140361-21-029025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-20 2021-08-19 ACMR McKechnie Mark See remarks S - Sale+OE $82.08 -5,000 726 -87% -$410.4K
D 2021-08-20 2021-08-19 ACMR McKechnie Mark See remarks M - OptEx $13.85 +5,000 5,000 New +$69.2K
D 2021-08-20 2021-08-19 ACMR McKechnie Mark See remarks M - OptEx $0.00 -5,000 15.0K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-08-19 S D 526 $82.74 200 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.73 to $83.00, inclusive.
2 Common Class A Common Stock 2021-08-19 S D 200 $83.89 0 D — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.88 to $83.89, inclusive.
3 Common Class A Common Stock 2021-08-19 S D 4,274 $81.91 726 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.65 to $82.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
4 Common Class A Common Stock 2021-08-19 M A 5,000 $13.85 5,000 D — —
5 Derivative Stock Option 2021-08-19 M D 5,000 $0.00 14,972 D $13.85 · — to 2028-07-31 5,000 Class A Common Stock (F6) The option vested and became exercisable as to 10,000 shares on August 1, 2019, and the remaining 30,000 shares vest and became or become exercisable in equal monthly installments over the following 36 months, subject to continued service through each vesting date.